Invention Grant
- Patent Title: Antibodies to the PcrV antigen of Pseudomonas aeruginosa
- Patent Title (中): 对铜绿假单胞菌PcrV抗原的抗体
-
Application No.: US13271146Application Date: 2011-10-11
-
Publication No.: US08877191B2Publication Date: 2014-11-04
- Inventor: Christopher R. Bebbington , Kenneth Luehrsen , Geoffrey T. Yarranton , Mark Baer
- Applicant: Christopher R. Bebbington , Kenneth Luehrsen , Geoffrey T. Yarranton , Mark Baer
- Applicant Address: US CA South San Francisco
- Assignee: KaloBios Pharmaceuticals, Inc.
- Current Assignee: KaloBios Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend and Stockton LLP
- Main IPC: A61K39/104
- IPC: A61K39/104 ; A61K39/395 ; C07K16/12
Abstract:
The current invention provides high-affinity antibodies to the Pseudomonas aeruginosa PcrV protein that have reduced immunogenicity when administered to treat Pseudomonas aeruginosa infections.
Public/Granted literature
- US20120020986A1 Antibodies to the PcrV Antigen of Pseudomonas aeruginosa Public/Granted day:2012-01-26
Information query
